CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
HypoSkin is an innovative testing kit using human skin biopsies to predict drug injection responses in subcutaneous tissue. This technology aims to reduce reliance on animal testing and improve the efficiency of drug development.
Subcutaneous injection drug market is highly increasing (CAGR of 7%) and is view as a viable alternative route for parenteral drug administration because it enables at-home injection, improves quality of life and reduces health care costs.
However, the absence of accurate biological model to predict the effect of drug injection in the subcutaneous tissue limits their development.
That issue leads to 88% of drug attrition causing a loss of more than €1B per developed drug and a sharp decrease of…
GENOSKIN SAS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
